Komori
EnBio Holdings,Inc (6092) · InitiativeAdvanced

Strengthening the Technology Development Structure and Securing New Technologies

First written in FY2016. 14 of 24 entries say "Restated". Latest entry: FY2026.

24entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020-Q2 – FY2021-Q3AdvancedFY2022 – FY20262016: 220162017: 420172018: 320182019: 420192020: 320202021: 320212022: 220222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「We are conducting R&D on concentration and separation technologies for PFOA and PFOS and developing separation equipment using these technologies. Concentrating and separating PFOA and PFOS in groundwater can substantially reduce the volume of material requiring treatment, with potential benefits including lower costs and reduced environmental impact.」

    In addition to its existing microbial technologies and in-situ permeable reactive barriers, the company is advancing concentration and separation technologies and equipment development for PFAS. R&D expenses are ¥26 million.
  2. FY2025AdvancedAnnual report

    「To respond rapidly to customer needs, we will strengthen the structure for developing, introducing and proposing new technologies and construction methods, centered on the Technology Strategy Department. This will include development using pollutant-degrading microorganisms through joint research with universities, the introduction from the United States of a new in-situ permeable barrier method, the Plume Stop method, development of remediation technologies for the new target substances PFAS (PFOA and PFOS), and sales of PFAS-free products.」

    In addition to developing and introducing new technologies and construction methods, the company identifies specific areas for technology development and proposals, including microorganisms, in-situ permeable barriers, PFAS remediation, and PFAS-free products.
  3. FY2023AdvancedAnnual report

    「During the fiscal year, the conformity review by the expert review panel for the Guidelines for the Use of Bioremediation by Microorganisms, supervised by the Ministry of Economy, Trade and Industry and the Ministry of the Environment, was completed, and the company received certificates confirming conformity with the guidelines from the Minister of Economy, Trade and Industry and the Minister of the Environment. The technology can now be used in actual projects.」

    The bioremediation method using the microbial consortium passed the conformity review under the guidelines and progressed to the stage at which it can be used in actual projects.
  4. FY2022AdvancedAnnual report

    「Following repeated consultations with the relevant departments of the Ministry of Economy, Trade and Industry and the Ministry of the Environment and with members of the expert committee, the company obtained broad approval and is expected to receive approval for use after the expert committee review in the next fiscal year.」

    For the microbial technology, the company has progressed to acquiring additional data and consulting with the relevant departments and experts for the conformity review, with use expected to be approved following the expert committee review in the next fiscal year.
  5. FY2022-Q3RestatedAnnual report

    「The amount spent on research and development activities across the group during the nine-month cumulative period was ¥4.538 million.」

    The company continues its research and development activities and discloses R&D expenses of ¥4.538 million for the nine-month cumulative period.
  6. FY2022-Q1RestatedAnnual report

    「The amount spent on research and development activities across the group during the three-month cumulative period was ¥1.778 million.」

    The company continues its research and development activities and discloses R&D expenses for the three-month cumulative period.
  7. FY2021AdvancedAnnual report

    「During the fiscal year, we compiled an application for the conformity review under the Guidelines for the Use of Bioremediation by Microorganisms, supervised by the Ministry of Economy, Trade and Industry and the Ministry of the Environment, using performance evaluation test data at laboratory scale and data confirming microbial behavior at the genetic level. We began consultations with the relevant departments and an expert committee and conducted surveys and additional experiments to address several comments. Development of a mass-cultivation method for a consortium including the relevant bacteria, which began in the previous fiscal year in preparation for commercialization, was completed using a beer-barrel-shaped cultivation apparatus.」

    For the microbial technology, the company advanced to compiling the application for the conformity review and beginning consultations, and also completed the mass-cultivation method. R&D expenses of ¥8.224 million were disclosed.
  8. FY2021-Q3RestatedAnnual report

    「The amount spent on research and development activities across the group during the nine-month cumulative period was ¥3.929 million.」

    The company continues its research and development activities and discloses R&D expenses of ¥3.929 million for the nine-month cumulative period.
  9. FY2021-Q2RestatedAnnual report

    「The amount spent on research and development activities across the group during the six-month cumulative period was ¥2.460 million.」

    The company continues its research and development activities and discloses R&D expenses for the six-month cumulative period.
  10. FY2021-Q1RestatedAnnual report

    「The amount spent on research and development activities across the group during the three-month cumulative period was ¥0.952 million.」

    The company continues its research and development activities and discloses R&D expenses for the three-month cumulative period.
  11. FY2020-Q3RestatedAnnual report

    「The amount spent on research and development activities across the group during the nine-month cumulative period was ¥18.077 million.」

    The company continues its research and development activities and discloses R&D expenses for the nine-month cumulative period.
  12. FY2020-Q2RestatedAnnual report

    「The amount spent on research and development activities across the group during the six-month cumulative period was ¥11.269 million.」

    The company continues its research and development activities and discloses R&D expenses of ¥11.269 million for the six-month cumulative period.
  13. FY2020-Q1AdvancedAnnual report

    「The capital and business alliance with 鉱研工業株式会社 began, strengthening sales capabilities in Japan and overseas and initiating joint development of technologies and services.」

    Joint development of technologies and services through the alliance with 鉱研工業 began, giving concrete form to external collaboration in the technology development structure.
  14. FY2019AdvancedAnnual report

    「During the fiscal year, as in the previous fiscal year, we worked to establish construction and operational management technologies through full-scale construction at actual contaminated sites and to develop the plant.」

    The company proceeded with establishing construction and operational management technologies through full-scale ISTD construction and recorded R&D expenses of ¥90.009 million.
  15. FY2019-Q3RestatedAnnual report

    「The amount spent on research and development activities across the group during the nine-month cumulative period was ¥81.926 million.」

    The company continues its research and development activities and discloses R&D expenses of ¥81.926 million for the nine-month cumulative period.
  16. FY2019-Q2RestatedAnnual report

    「The amount spent on research and development activities across the group during the six-month cumulative period was ¥71.374 million.」

    The company continues its research and development activities and discloses R&D expenses for the six-month cumulative period.
  17. FY2019-Q1RestatedAnnual report

    「The amount spent on research and development activities across the group during the three-month cumulative period was ¥1.952 million.」

    The company continues its research and development activities and discloses R&D expenses for the three-month cumulative period.
  18. FY2018-Q3AdvancedAnnual report

    「As one of these initiatives, we opened a group research and development center after renovating a building.」

    The company progressed through the acquisition and renovation of a brownfield property to the stage of opening a group research and development center.
  19. FY2018-Q2RestatedAnnual report

    「The amount spent on research and development activities across the group during the six-month cumulative period was ¥8.061 million.」

    The company continues its research and development activities and discloses R&D expenses for the six-month cumulative period.
  20. FY2018-Q1RestatedAnnual report

    「The amount spent on research and development activities across the group during the three-month cumulative period was ¥0.890 million.」

    The company continues its research and development activities and discloses R&D expenses for the three-month cumulative period.
  21. FY2017AdvancedAnnual report

    「We introduced technologies relating to design methods, equipment specifications and construction methods, established testing methods to assess applicability for full-scale construction at actual contaminated sites, carried out remediation design work including well layout and calculations of heat, gas and treated-water volumes at sites, and designed and manufactured treatment equipment. R&D expenses for the fiscal year were ¥21.311 million.」

    The company proceeded with technology introduction, establishment of testing methods, remediation design, and equipment design and manufacturing, including ISTD, and also disclosed its R&D expenses.
  22. FY2017-Q3RestatedAnnual report

    「The amount spent on research and development activities across the group during the nine-month cumulative period was ¥15.917 million.」

    The company continues its research and development activities and discloses R&D expenses for the nine-month cumulative period.
  23. FY2017-Q2RestatedAnnual report

    「The amount spent on research and development activities across the group during the six-month cumulative period was ¥1.914 million.」

    The company continues its research and development activities and discloses R&D expenses for the cumulative period.
  24. FY2016First statedAnnual report

    「In addition to in-house technology development, we are actively pursuing joint research with universities in Japan and overseas and the introduction of technologies from leading overseas companies. In March 2016, we acquired the rights to implement in-situ thermal treatment technology already in commercial use in the United States and Europe.」

    The policy is to combine in-house development, joint research with universities, and the introduction of overseas technologies.
Moved together

"Acquisition, remediation and resale or leasing of contaminated land" moved the same way as this thread, in the same document, in 8 of its 24 moves.

877665★123456
  1. ★This thread
  2. 1Acquisition, remediation and resale or leasing of contaminated land8×
  3. 2Expansion of Renewable Energy Business7×
  4. 3Technology Development for Newly Regulated and Difficult-to-Treat Substances7×
  5. 4Improving the ratio of prime-contract orders and reducing the cost ratio through greater management efficiency6×
  6. 5Strengthening the Value Chain through Partnerships6×
  7. 6A business model centered on in-situ and on-site remediation as core competitive advantages5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for EnBio Holdings,Inc yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.